Xiao-Jun Ma

Xiao-Jun Ma's Title

Xiao-Jun Ma currently holds the position of Chief Technology Officer (CTO) at Alamar Biosciences, a role he has been serving in since June of 2021. As CTO, he is responsible for overseeing the technological direction of the company, driving innovation, and ensuring the alignment of technology with the company's strategic goals. His extensive background in life sciences and molecular diagnostics makes him a pivotal figure in advancing Alamar Biosciences' technological capabilities.

Xiao-Jun Ma's Company

Xiao-Jun Ma joined Alamar Biosciences in June of 2021, bringing with him a wealth of experience in the life sciences sector. Alamar Biosciences is at the forefront of developing cutting-edge technologies aimed at revolutionizing the field of molecular diagnostics. Under Ma's technological leadership, the company is poised to make significant strides in the detection and diagnosis of diseases, leveraging his extensive expertise in genomics and bioinformatics.

Xiao-Jun Ma's Experience

With over 20 years of experience in the life sciences and molecular diagnostics industries, Xiao-Jun Ma has a distinguished career characterized by significant contributions to the field. Prior to his current role at Alamar Biosciences, he served as Vice President and Chief Scientific Officer in the Genomics Division of Bio-Techne. Additionally, he spent 11 years at Advanced Cell Diagnostics (ACD), where he led the development of a world-leading portfolio of in situ RNA and DNA detection solutions. His career also includes pivotal roles at bioTheranostics, Johnson & Johnson, and Monsanto/Searle (Pfizer), where he applied his multidisciplinary knowledge to discover novel drug targets and biomarkers.

Xiao-Jun Ma's Achievements

Xiao-Jun Ma has a notable track record of achievements within the life sciences industry. At Advanced Cell Diagnostics, he spearheaded the development of innovative RNA and DNA detection solutions that are now widely used in research and clinical diagnostics. His tenure at bioTheranostics saw him in the role of Vice President of R&D/Biostatistics, leading significant advancements prior to the company's acquisition by Hologic, Inc. His work has consistently involved the integration of molecular biology and bioinformatics to push the boundaries of medical research and diagnostics.

Xiao-Jun Ma's Education and Expertise

Xiao-Jun Ma's educational background is as impressive as his professional experience. He received his doctorate training in biochemistry at Case Western Reserve University and the University of Iowa. He further honed his expertise with post-doctoral training in molecular genetics at the University of California, Los Angeles. This robust educational foundation has equipped him with deep expertise in molecular biology and bioinformatics, enabling him to make groundbreaking contributions to the life sciences and diagnostics fields.